BAP1 Gene Tumor Predisposition Syndrome Genetic Test
Introduction
The BAP1 gene is a tumor suppressor gene that plays a crucial role in preventing the development of certain types of cancer. Mutations in the BAP1 gene can lead to a condition known as BAP1 gene tumor predisposition syndrome, which significantly increases the risk of developing various types of tumors, including uveal melanoma, malignant mesothelioma, and renal cell carcinoma.
NGS Technology
NGS (Next-Generation Sequencing) genetic testing is a state-of-the-art technique used to analyze multiple genes simultaneously, enabling the identification of genetic mutations or variations. In the case of BAP1 gene tumor predisposition syndrome, NGS genetic testing can detect mutations in the BAP1 gene that may increase an individual’s risk of developing cancer.
Test Details
The BAP1 gene tumor predisposition syndrome genetic test requires a sample of DNA, which can be obtained through a blood or saliva sample. The DNA is then analyzed using NGS technology to identify various types of mutations in the BAP1 gene, including small point mutations, insertions, deletions, and larger structural rearrangements.
Test Components and Price
The BAP1 Gene Tumor Predisposition Syndrome Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results are typically delivered within 3 to 4 weeks after the sample is received.
Doctor and Test Department
The BAP1 Gene Tumor Predisposition Syndrome Genetic Test is conducted under the supervision of an oncologist in the Genetics department.
Pre Test Information
Prior to undergoing the BAP1 Gene Tumor Predisposition Syndrome Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by BAP1 gene tumor predisposition syndrome.
Importance of the Test
The results of the NGS genetic test can provide crucial information about an individual’s risk of developing cancer associated with BAP1 gene mutations. This information can guide medical management, screening recommendations, preventive measures, and treatment options for both the individual and their family members.
Conclusion
BAP1 Gene Tumor Predisposition Syndrome Genetic Test is a valuable tool in identifying individuals at risk of developing various types of tumors. With the help of NGS technology, this test can detect mutations in the BAP1 gene, providing important information for medical decision-making and genetic counseling.
| Test Name | BAP1 Gene Tumor predisposition syndrome Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for BAP1 Gene Tumor predisposition syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BAP1 Gene Tumor predisposition syndrome NGS Genetic DNA Test gene BAP1 |
| Test Details | The BAP1 gene is a tumor suppressor gene that plays a role in preventing the development of certain types of cancer. Mutations in the BAP1 gene can lead to a condition called BAP1 gene tumor predisposition syndrome, which increases the risk of developing various types of tumors, including uveal melanoma, malignant mesothelioma, and renal cell carcinoma. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify genetic mutations or variations. In the context of BAP1 gene tumor predisposition syndrome, NGS genetic testing can be used to identify mutations in the BAP1 gene that may increase an individual’s risk of developing cancer. NGS genetic testing for BAP1 gene tumor predisposition syndrome involves obtaining a sample of DNA, typically through a blood or saliva sample, and analyzing it using NGS technology. The test can detect various types of mutations in the BAP1 gene, including small point mutations, insertions, deletions, and larger structural rearrangements. The results of the NGS genetic test can provide important information about an individual’s risk of developing cancer associated with BAP1 gene mutations. This information can be used to guide medical management and screening recommendations for individuals and their families. It can also help in making informed decisions about preventive measures and treatment options. It is important to note that NGS genetic testing for BAP1 gene tumor predisposition syndrome is typically recommended for individuals with a personal or family history of tumors associated with BAP1 gene mutations. Genetic counseling is often recommended before and after testing to help individuals understand the implications of the test results and make informed decisions. |
